Mobile Medical Applications: Understanding FDA’s Final Guidance

Please join us for a one-hour webinar to discuss the Food and Drug Administration's new final guidance on mobile medical applications.

Topics will include:

• An overview of the differences between the draft and final guidance documents
• The types of apps FDA intends to actively regulate and the types that are subject to enforcement discretion
• Regulatory impact for software developers, mobile platform manufacturers, and others involved in the development and sale of mobile medical apps

When:
Wednesday, October 9, 2013
12–1 pm ET

Presenters:
Elizabeth Bierman  |  Partner, Washington, D.C.
Tony Pavel  |  Partner, Washington, D.C.
Michele Buenafe  |  Associate, Washington, D.C.

CLE Credit:
CLE credit in CA, NJ, NY, PA, and TX is pending approval.